Sickle Cell
Protocol:GBT440-034
Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: An Open Label Extension Study GBT440 administered Orally to Patients with Sickle Cell Disease Who Have Participate in GBR440 Clinical Trials.
Principal I investigator: Alan Ikeda, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03573882
Cure 4 The Kids Foundation (C4K) is pleased to announce the addition of Dr. Suraj Pratap, M.D. to their team of healthcare providers. Dr. Pratap brings with him a wealth of experience, having previously practiced general pediatrics in Las Vegas. He recently obtained his board-certification in pediatric hematology oncology, which will provide additional resources and expertise to C4K’s existing team of seven providers. Fluent in both English and Hindi, Dr. Pratap is now seeing C4K patients.
Christmas 4 The Kids Digital Album Benefits Pediatric Patients at Cure 4 The Kids Foundation
